<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50235">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01854229</url>
  </required_header>
  <id_info>
    <org_study_id>PAS-01</org_study_id>
    <nct_id>NCT01854229</nct_id>
  </id_info>
  <brief_title>Prometra Post-Approval Study</brief_title>
  <official_title>A Prospective, Non-randomized, Open-label, Multicenter Study to Evaluate the Long-term Safety of the Prometra Programmable Pump System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Flowonix Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Flowonix Medical</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Prometra Pump is approved by the FDA for use in the United States.  The purpose of this
      study is to collect long-term safety data on the Prometra Pump.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is proposed under part of the post-Premarket Approval (PMA) requirements.  This
      study is a prospective, non-randomized, open-label, multicenter study. It will be performed
      at 10-30 centers in the US and enroll a maximum of 400 subjects. Subjects will be followed
      for a total of five years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rate of granuloma formation</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The primary hypothesis is that the 5-year rate of patients with granuloma formation will be noninferior to that in the literature. The literature rate was found to be approximately 3% and the noninferiority margin will be three percentage points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pump failure</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Tabulation of pump failures, including time to occurrence and type</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pump battery life</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Tabulation of occurences of premature pump battery depletions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Device-related adverse events</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Tabulation of device-related adverse events</description>
  </other_outcome>
  <other_outcome>
    <measure>Device-related serious adverse events</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Tabulation of device-related serious adverse events</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of granuloma formation by race and ethnicity</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The effect of race and ethnicity on granuloma formation</description>
  </other_outcome>
  <other_outcome>
    <measure>Granuloma formation by drug type</measure>
    <time_frame>Five years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The effect of alternative drugs on granuloma formation</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Chronic Pain</condition>
  <condition>Cancer Pain</condition>
  <condition>Intractable Pain</condition>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Prospective pump candidates</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>New candidates who will receive the Prometra Programmable Intrathecal Infusion Pump</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Previous IDE-study subjects continuing with the therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who were part of the previous IDE-study, still have an active Prometra Programmable Intrathecal Infusion Pump, and are willing to continue in a study protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prometra Programmable Intrathecal Infusion Pump</intervention_name>
    <description>There are two enrollment groups (arms).  One is for new patients who are going to have a Prometra Pump implanted.  The other arm is for patients who were part of the IDE-study prior to FDA approval of the pump, and are willing to continue to be followed as part of a study.</description>
    <arm_group_label>Prospective pump candidates</arm_group_label>
    <arm_group_label>Previous IDE-study subjects continuing with the therapy</arm_group_label>
    <other_name>Flowonix pump</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient meets at least one of the following:

               -  is suffering from malignant pain (i.e., cancer pain)

               -  has chronic, non-malignant pain

               -  subject was enrolled in PUMP I or PUMP II study and chooses to participate in
                  this Post-Approval study

               -  Patient with an existing implantable pump for pain therapy that requires
                  replacement

          2. Patient is at least 22 years of age.

          3. Investigator considers the patient to be able and willing to fulfill all study
             requirements.

          4. Patient has provided written informed consent to participate in the study.

        Exclusion Criteria:

          1. Patient meets any of the contraindications for use of the Prometra System

          2. Patient has a prior history of granuloma formation, or is receiving treatment for a
             suspected granuloma.

          3. Patient is pregnant or breast-feeding or is of child-bearing potential and not
             employing effective birth control.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Janelle Arrambide</last_name>
    <phone>973 426 9229</phone>
    <email>jarrambide@flowonix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jill Schweiger</last_name>
    <phone>973 426 9229</phone>
    <email>jschweiger@flowonix.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samaritan Center for Medical Research</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathy Wall</last_name>
      <phone>408-356-0503</phone>
    </contact>
    <investigator>
      <last_name>Maia Chakerian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Diego Comprehensive Pain Management Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacy Gordon</last_name>
      <phone>619-640-5555</phone>
    </contact>
    <investigator>
      <last_name>David J Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Pain Physicians</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Placencia</last_name>
      <phone>805-563-0363</phone>
    </contact>
    <investigator>
      <last_name>R. Michael Hullander, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph D Mozingo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Pain &amp; Headache Treatment Center</name>
      <address>
        <city>Derby</city>
        <state>Connecticut</state>
        <zip>06418</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Alfonso, NP</last_name>
      <phone>203-732-1570</phone>
    </contact>
    <investigator>
      <last_name>Mark Thimineur, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Medical Clinic</name>
      <address>
        <city>Land O' Lakes</city>
        <state>Florida</state>
        <zip>34639</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daily Johnston</last_name>
      <phone>813-712-5700</phone>
    </contact>
    <investigator>
      <last_name>Abraham Rivera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Medical &amp; Pain Management Research Clinic</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33145</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Drouillard</last_name>
      <phone>305-646-6955</phone>
    </contact>
    <investigator>
      <last_name>Abel Murillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pain Institute of Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Barsa, MD</last_name>
      <phone>813-875-5913</phone>
    </contact>
    <investigator>
      <last_name>John Barsa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Summit Pain Management</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hillary Osbon</last_name>
      <phone>260-748-3650</phone>
    </contact>
    <investigator>
      <last_name>Michael Cozzi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bluegrass Pain Consultants</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Bruner, RN</last_name>
      <phone>502-423-1021</phone>
    </contact>
    <investigator>
      <last_name>Christopher Nelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuroscience and Pain Institute</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Guidry, NP-C</last_name>
      <phone>985-892-8934</phone>
    </contact>
    <investigator>
      <last_name>Chad M Domangue, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jackson Anesthesia Pain Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Griffith</last_name>
      <phone>601-709-0607</phone>
    </contact>
    <investigator>
      <last_name>Carroll M McLeod, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Triumph Medical</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Jones, RN</last_name>
      <phone>828-694-4548</phone>
    </contact>
    <investigator>
      <last_name>Javid Baksh, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pain Management Institute</name>
      <address>
        <city>Wooster</city>
        <state>Ohio</state>
        <zip>44691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AlexSandra Davis, RN</last_name>
      <phone>330-263-8478</phone>
    </contact>
    <investigator>
      <last_name>A. Harris Basali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurospine Institute</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn Potts</last_name>
      <phone>541-686-3791</phone>
    </contact>
    <investigator>
      <last_name>Gregory A Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Phillips, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pain Care of Oregon</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Sefert</last_name>
      <phone>541-608-1990</phone>
    </contact>
    <investigator>
      <last_name>Joseph Savino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Johnston, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Chase Pain Management Associates</name>
      <address>
        <city>Trevose</city>
        <state>Pennsylvania</state>
        <zip>19053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Michael, RN</last_name>
      <phone>267-288-5601</phone>
    </contact>
    <investigator>
      <last_name>Steven Rosen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Bromberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Ferrara, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nexus Pain Care</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiona MacKay</last_name>
      <phone>801-356-6100</phone>
    </contact>
    <investigator>
      <last_name>Richard Rosenthal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.aapainmanage.org/</url>
    <description>American Academy of Pain Management</description>
  </link>
  <link>
    <url>http://www.painmed.org/</url>
    <description>American Academy of Pain Medicine</description>
  </link>
  <link>
    <url>http://www.neuromodulation.org/</url>
    <description>North American Neuromodulation Society</description>
  </link>
  <link>
    <url>http://www.worldinstituteofpain.org/site/home.php</url>
    <description>World Institute of Pain</description>
  </link>
  <link>
    <url>http://www.asra.com/</url>
    <description>American Society of Regional Anesthesia and Pain Medicine</description>
  </link>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 8, 2014</lastchanged_date>
  <firstreceived_date>May 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Morphine</keyword>
  <keyword>Implantable Infusion Pumps</keyword>
  <keyword>Intrathecal Pump</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Pain, Intractable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
